Document Preview Unavailable

The neutralization potency of anti-SARS-CoV-2 therapeutic human monoclonal antibodies is retained against novel viral variants

Rosenfeld, Ronit; Mazor, Ohad; Makdasi, Efi; Zvi, Anat; Alcalay, Ron; et al.  bioRxiv, Apr 1, 2021.

You might have access to this document